share_log

腾盛博药-B(02137)授出合共575.25万份购股权及82.15万份受限制股份单位

Tengsheng Pharmaceutical-B (02137) granted a total of 5.752,500 share options and 821,500 restricted share units

Zhitong Finance ·  Mar 29 01:18

Tengsheng Pharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company purchased shares in accordance with 2023...

According to Zhitong Finance App, Tengsheng BioPharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company granted a total of 5.752,500 share purchase rights to 55 share purchase rights under the terms of the 2023 share purchase plan, and granted a total of 821,500 restricted share units to 18 restricted share unit grantees in accordance with the terms of the 2023 share award plan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment